SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 152 filers reported holding SERES THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,484 | -50.3% | 49,363 | 0.0% | 0.04% | -40.3% |
| Q2 2023 | $236,449 | -15.5% | 49,363 | 0.0% | 0.07% | -28.7% |
| Q1 2023 | $279,888 | +1.2% | 49,363 | 0.0% | 0.09% | +1.1% |
| Q4 2022 | $276,433 | -12.8% | 49,363 | 0.0% | 0.09% | -10.6% |
| Q3 2022 | $317,000 | +87.6% | 49,363 | 0.0% | 0.10% | +89.1% |
| Q2 2022 | $169,000 | -51.9% | 49,363 | 0.0% | 0.06% | -23.6% |
| Q1 2022 | $351,000 | -14.6% | 49,363 | 0.0% | 0.07% | +35.8% |
| Q4 2021 | $411,000 | +19.5% | 49,363 | 0.0% | 0.05% | +65.6% |
| Q3 2021 | $344,000 | -70.8% | 49,363 | 0.0% | 0.03% | -71.7% |
| Q2 2021 | $1,177,000 | +15.8% | 49,363 | 0.0% | 0.11% | -16.9% |
| Q1 2021 | $1,016,000 | -50.6% | 49,363 | -41.2% | 0.14% | -83.1% |
| Q4 2020 | $2,056,000 | – | 83,903 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $125,560,000 | 40.85% |
| ARK Investment Management | 492,064 | $4,871,000 | 1.77% |
| Artal Group S.A. | 700,000 | $6,930,000 | 0.15% |
| Portolan Capital Management | 111,054 | $1,099,000 | 0.15% |
| Rock Springs Capital Management LP | 220,000 | $2,178,000 | 0.15% |
| CQS Cayman LP | 162,000 | $1,604,000 | 0.13% |
| Opus Point Partners Management, LLC | 14,000 | $139,000 | 0.11% |
| HAMILTON LANE ADVISORS LLC | 14,883 | $147,000 | 0.10% |
| Geduld E E | 15,000 | $149,000 | 0.08% |
| Virtus ETF Advisers LLC | 28,148 | $279,000 | 0.08% |